Allele-linked divergence in SlpA and TcdB drives distinct immune and cytotoxic responses that distinguish ST01 from non-ST01 strains in Clade 2 Clostridioides difficile

References

1. Finn E, Andersson FL, Madin-Warburton M. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI. BMC Infect Dis 2021; 21:456 [View Article] [PubMed]
   [Google Scholar]
2. Yu H, Alfred T, Nguyen JL, Zhou J, Olsen MA. Incidence, attributable mortality, and healthcare and out-of-pocket costs of Clostridioides difficile infection in US medicare advantage enrollees. Clin Infect Dis 2023; 76:e1476–e1483 [View Article] [PubMed]
   [Google Scholar]
3. Smith AB, Soto Ocana J, Zackular JP. From nursery to nursing home: emerging concepts in Clostridioides difficile pathogenesis. Infect Immun 2020; 88:00934–19 [View Article] [PubMed]
   [Google Scholar]
4. Griffiths D, Fawley W, Kachrimanidou M, Bowden R, Crook DW et al. Multilocus sequence typing of Clostridium difficile. J Clin Microbiol 2010; 48:770–778 [View Article] [PubMed]
   [Google Scholar]
5. Dingle KE, Griffiths D, Didelot X, Evans J, Vaughan A et al. Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One 2011; 6:e19993 [View Article] [PubMed]
   [Google Scholar]
6. O’Connor JR, Johnson S, Gerding DN. Clostridium difficile Infection Caused by the Epidemic BI/NAP1/027 Strain. Gastroenterology 2009; 136:1913–1924 [View Article]
   [Google Scholar]
7. Kuijper EJ, Coignard B, Tüll P et al. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006; 12 Suppl 6:2–18 [View Article] [PubMed]
   [Google Scholar]
8. Merrigan M, Venugopal A, Mallozzi M, Roxas B, Viswanathan VK et al. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol 2010; 192:4904–4911 [View Article] [PubMed]
   [Google Scholar]
9. Drudy D, Kyne L, O’Mahony R, Fanning S. gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027. Emerg Infect Dis 2007; 13:504–505 [View Article] [PubMed]
   [Google Scholar]
10. Orozco-Aguilar J, Alfaro-Alarcón A, Acuña-Amador L, Chaves-Olarte E, Rodríguez C et al. In vivo animal models confirm an increased virulence potential and pathogenicity of the NAP1/RT027/ST01 genotype within the Clostridium difficile MLST Clade 2. Gut Pathog 2020; 12:45 [View Article] [PubMed]
    [Google Scholar]
11. Quesada-Gómez C, López-Ureña D, Acuña-Amador L, Villalobos-Zúñiga M, Du T et al. Emergence of an outbreak-associated Clostridium difficile variant with increased virulence. J Clin Microbiol 2015; 53:1216–1226 [View Article] [PubMed]
    [Google Scholar]
12. See I, Mu Y, Cohen J, Beldavs ZG, Winston LG et al. NAP1 strain type predicts outcomes from Clostridium difficile infection. Clin Infect Dis 2014; 58:1394–1400 [View Article] [PubMed]
    [Google Scholar]
13. Badilla-Lobo A, Rodríguez C. Microbiological features, epidemiology, and clinical presentation of Clostridioidesdifficile strains from MLST clade 2: a narrative review. Anaerobe 2021; 69:102355 [View Article] [PubMed]
    [Google Scholar]
14. Ramírez-Vargas G, López-Ureña D, Badilla A, Orozco-Aguilar J, Murillo T et al. Novel Clade C-I Clostridium difficile strains escape diagnostic tests, differ in pathogenicity potential and carry toxins on extrachromosomal elements. Sci Rep 2018; 8:1 [View Article]
    [Google Scholar]
15. Killgore G, Thompson A, Johnson S, Brazier J, Kuijper E et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol 2008; 46:431–437 [View Article] [PubMed]
    [Google Scholar]
16. Karlowsky JA, Zhanel GG, Hammond GW, Rubinstein E, Wylie J et al. Multidrug-resistant North American pulsotype 2 Clostridium difficile was the predominant toxigenic hospital-acquired strain in the province of Manitoba, Canada, in 2006-2007. J Med Microbiol 2012; 61:693–700 [View Article] [PubMed]
    [Google Scholar]
17. Guerrero-Araya E, Muñoz M, Rodríguez C, Paredes-Sabja D. FastMLST: a multi-core tool for multilocus sequence typing of draft genome assemblies. Bioinform Biol Insights 2021; 15: [View Article] [PubMed]
    [Google Scholar]
18. Dong Q, Lin H, Allen M-M, Garneau JR, Sia JK et al. Virulence and genomic diversity among clinical isolates of ST1 (BI/NAP1/027) Clostridioides difficile. Cell Reports 2023; 42:112861 [View Article]
    [Google Scholar]
19. Paredes-Sabja D, Sarker MR. Adherence of Clostridium difficile spores to Caco-2 cells in culture. J Med Microbiol 2012; 61:1208–1218 [View Article] [PubMed]
    [Google Scholar]
20. Paredes-Sabja D, Bond C, Carman RJ, Setlow P, Sarker MR. Germination of spores of Clostridium difficile strains, including isolates from a hospital outbreak of Clostridium difficile-associated disease (CDAD). Microbiology 2008; 154:2241–2250 [View Article] [PubMed]
    [Google Scholar]
21. Twine SM, Reid CW, Aubry A, McMullin DR, Fulton KM et al. Motility and flagellar glycosylation in Clostridium difficile. J Bacteriol 2009; 191:7050–7062 [View Article] [PubMed]
    [Google Scholar]
22. Baban ST, Kuehne SA, Barketi-Klai A, Cartman ST, Kelly ML et al. The role of flagella in Clostridium difficile pathogenesis: comparison between a non-epidemic and an epidemic strain. PLoS One 2013; 8:e73026 [View Article] [PubMed]
    [Google Scholar]
23. Karpiński P, Wultańska D, Piotrowski M, Brajerova M, Mikucka A et al. Motility and the genotype diversity of the flagellin genes fliC and fliD among Clostridioides difficile ribotypes. Anaerobe 2022; 73:102476 [View Article] [PubMed]
    [Google Scholar]
24. Calabi E, Ward S, Wren B, Paxton T, Panico M et al. Molecular characterization of the surface layer proteins from Clostridium difficile. Mol Microbiol 2001; 40:1187–1199 [View Article] [PubMed]
    [Google Scholar]
25. Quesada-Gómez C, Murillo T, Arce G, Badilla-Lobo A, Castro-Peña C et al. Proteogenomic analysis of the Clostridium difficile exoproteome reveals a correlation between phylogenetic distribution and virulence potential. Anaerobe 2020; 62:102151 [View Article] [PubMed]
    [Google Scholar]
26. Ðapa T, Leuzzi R, Ng YK, Baban ST, Adamo R et al. Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J Bacteriol 2013; 195:545–555 [View Article] [PubMed]
    [Google Scholar]
27. Otto A, Maaß S, Bonn F, Büttner K, Becher D. Chapter One - An easy and fast protocol for affinity bead-based protein enrichment and storage of proteome samples. In Shukla AK. eds Methods in Enzymology Academic Press; 2017 pp 1–13 [View Article]
    [Google Scholar]
28. López-Ureña D, Orozco-Aguilar J, Chaves-Madrigal Y, Ramírez-Mata A, Villalobos-Jimenez A et al. Toxin B variants from Clostridium difficile strains VPI 10463 and NAP1/027 share similar substrate profile and cellular intoxication kinetics but use different host cell entry factors. Toxins (Basel) 2019; 11:348 [View Article] [PubMed]
    [Google Scholar]
29. Vohra P, Poxton IR. Efficacy of decontaminants and disinfectants against Clostridium difficile. J Med Microbiol 2011; 60:1218–1224 [View Article] [PubMed]
    [Google Scholar]
30. González-Carballo GC, Rodríguez C. Resistance of Clostridioides difficile spores (Clostridiales: Peptostreptococcaceae) to sodium dichloroisocyanurate. Rev Biol Trop 2021; 69:755–762 [View Article]
    [Google Scholar]
31. Fraise AP, Wilkinson MAC, Bradley CR, Paton S, Walker J et al. Development of a sporicidal test method for Clostridium difficile. J Hosp Infect 2015; 89:2–15 [View Article] [PubMed]
    [Google Scholar]
32. Luo J, Yang Q, Zhang X, Zhang Y, Wan L et al. TFPI is a colonic crypt receptor for TcdB from hypervirulent clade 2 C. difficile. Cell 2022; 185:980–994 [View Article] [PubMed]
    [Google Scholar]
33. Shen E, Zhu K, Li D, Pan Z, Luo Y et al. Subtyping analysis reveals new variants and accelerated evolution of Clostridioides difficile toxin B. Commun Biol 2020; 3:1–8 [View Article]
    [Google Scholar]
34. Quesada-Gómez C, López-Ureña D, Chumbler N, Kroh HK, Castro-Peña C et al. Analysis of TcdB proteins within the hypervirulent clade 2 reveals an impact of RhoA glucosylation on Clostridium difficile proinflammatory activities. Infect Immun 2016; 84:856–865 [View Article] [PubMed]
    [Google Scholar]
35. Lanis JM, Barua S, Ballard JD. Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile. PLoS Pathog 2010; 6:e1001061 [View Article] [PubMed]
    [Google Scholar]
36. Chaves-Olarte E, Freer E, Parra A, Guzmán-Verri C, Moreno E et al. R-Ras glucosylation and transient RhoA activation determine the cytopathic effect produced by toxin B variants from toxin a-negative strains of Clostridium difficile. J Biol Chem 2003; 278:7956–7963 [View Article] [PubMed]
    [Google Scholar]
37. Di Bella S, Ascenzi P, Siarakas S, Petrosillo N, Di Masi A. Clostridium difficile toxins A and B: insights into pathogenic properties and extraintestinal effects. Toxins 2016; 8:134 [View Article]
    [Google Scholar]
38. Lim SK, Stuart RL, Mackin KE, Carter GP, Kotsanas D et al. Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain. Clin Infect Dis 2014; 58:1723–1730 [View Article] [PubMed]
    [Google Scholar]
39. Costa CL, López-Ureña D, de Oliveira Assis T, Ribeiro RA, Silva ROS et al. A MLST Clade 2 Clostridium difficile strain with a variant TcdB induces severe inflammatory and oxidative response associated with mucosal disruption. Anaerobe 2016; 40:76–84 [View Article] [PubMed]
    [Google Scholar]
40. Anjuwon-Foster BR, Tamayo R. A genetic switch controls the production of flagella and toxins in Clostridium difficile. PLoS Genet 2017; 13:e1006701 [View Article] [PubMed]
    [Google Scholar]
41. Garrett EM, Sekulovic O, Wetzel D, Jones JB, Edwards AN et al. Phase variation of a signal transduction system controls Clostridioides difficile colony morphology, motility, and virulence. PLoS Biol 2019; 17:e3000379 [View Article] [PubMed]
    [Google Scholar]
42. Reyes Ruiz LM, King KA, Agosto-Burgos C, Gamez IS, Gadda NC et al. Coordinated modulation of multiple processes through phase variation of a c-di-GMP phosphodiesterase in Clostridioides difficile. PLoS Pathog 2022; 18:e1010677 [View Article] [PubMed]
    [Google Scholar]